England’s Innovative Medicines Fund: Opportunities & Risks
England’s Innovative Medicines Fund could make the UK a more attractive launch market following Brexit, but companies must also consider the risks of the fund.
You may also be interested in...
The new financing mechanism promises faster access to new treatments, but some industry concerns remain unresolved.
The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.
The number of conditional marketing authorization non-renewals could increase.